Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

被引：0
|
作者：
T. Byrski
J. Gronwald
T. Huzarski
E. Grzybowska
M. Budryk
M. Stawicka
T. Mierzwa
M. Szwiec
R. Wiśniowski
M. Siolek
S. A. Narod
J. Lubinski
机构：
[1] Pomeranian Medical University,Department of Genetics and Pathology, International Hereditary Cancer Center
[2] Maria Sklodowska-Curie Memorial Institute,Department of Tumor Biology, Centre of Oncology
[3] Prophylactic and Epidemiology Center,Women’s College Research Institute
[4] Regional Oncology Hospital,undefined
[5] Regional Oncology Center,undefined
[6] Regional Oncology Hospital,undefined
[7] Holy Cross Oncology Center,undefined
[8] University of Toronto,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 108卷
关键词：
Taxane; Neo-adjuvant chemotherapy; BRCA1; Breast cancer; Doxorubicin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：289 / 296
页数：7
相关论文
共 50 条
  • [41] The impact of molecular subtypes of breast carcinoma on response to neo-adjuvant chemotherapy in Asian population
    Nasir, I. U. I.
    Salim, M.
    Shakeel, O.
    Abubakar, M.
    Pervaiz, A.
    Khan, A. I.
    BREAST, 2019, 44 : S75 - S76
  • [42] Histologic changes in breast carcinoma after neo-adjuvant chemotherapy correlate with pathologic response
    Sullivan, P. S.
    Apple, S. K.
    MODERN PATHOLOGY, 2007, 20 : 51A - 51A
  • [43] Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
    GJ Bansal
    D Santosh
    Cancer Imaging, 15 (Suppl 1)
  • [44] Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer
    Xi Gu
    Yang Zhang
    Long Chen
    Jiao Guo
    Wen-Hai Zhang
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 301 - 308
  • [45] Pathologic Predictors of Treatment Response to Neo-adjuvant Chemotherapy for Invasive Lobular Breast Carcinoma
    Tsai, Michaela
    Finkelstein, Marsha
    Lillemoe, Tamera
    Susnik, Barbara
    Grimm, Erin
    Kang, Sung-Hae
    Kelly, Caitlin
    Swenson, Karen
    BREAST JOURNAL, 2017, 23 (05): : 607 - 609
  • [46] Exploring patient experiences of neo-adjuvant chemotherapy for breast cancer
    Beaver, K.
    Williamson, S.
    Briggs, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S374 - S375
  • [47] Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis
    Shao, ZM
    Li, J
    Wu, J
    Han, QX
    Shen, ZZ
    Fontana, JA
    Barsky, SH
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 53 (03) : 263 - 269
  • [48] Role of neo-adjuvant chemotherapy in locally advanced breast cancer
    Akhtar, M.
    Akulwar, V
    Kulkarni, A.
    Bansal, A.
    INDIAN JOURNAL OF CANCER, 2015, 52 (03) : 286 - U305
  • [49] Management of inflammatory breast cancer after neo-adjuvant chemotherapy
    Abrous-Anane, S.
    Savignoni, A.
    Daveau, C.
    Pierga, J. -Y.
    Gautier, C.
    Reyal, F.
    Dendale, R.
    Campana, F.
    Kirova, Y.
    Fourquet, A.
    Bollet, M. -A.
    CANCER RADIOTHERAPIE, 2011, 15 (08): : 654 - 662
  • [50] Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer
    Gu, Xi
    Zhang, Yang
    Chen, Long
    Guo, Jiao
    Zhang, Wen-Hai
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 301 - 308
12345